Dopamine → Morphine

HRID 447707

반응식

HRID 447707 반응식
NCCC1C=CC(O)=CC=1.NCCC1C=CC(O)=C(O)C=1.COC1C=CC2N=CC=C([C@H](O)[C@@H]3N4C[C@H](C=C)C(CC4)C3)C=2C=1.[CH3:46][N:47]1[CH:56]([CH2:57][C:58]2[CH:59]=[CH:60][C:61]([O:65]C)=[C:62]([OH:64])[CH:63]=2)[C:55]2[CH:54]=[C:53](O)[C:52]([O:68]C)=[CH:51][C:50]=2[CH2:49][CH2:48]1.CN1[C@@H]2CC3C=CC(OC)=C4O[C@H]5[C@@H](O)C=C[C@@H]2[C@]5(C=34)CC1>>[CH:59]1[C:58]2[CH2:57][C@H:56]3[N:47]([CH2:48][CH2:49][C@@:50]45[C@H:55]3[CH:54]=[CH:53][C@H:52]([OH:68])[C@@H:51]4[O:64][C:62]([C:63]=25)=[C:61]([OH:65])[CH:60]=1)[CH3:46]

참가 물질

6

반응물 5

HCID 681Dopamine5회HCID 5610Tyramine3회HCID 5953(S)-[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol2회HCID 102331-((3-Hydroxy-4-methoxyphenyl)methyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-olHCID 5284371Codeine

생성물 1

HCID 5288826Morphine

실험 절차

To examine the tyramine to dopamine step, dopamine (DA) levels in ganglia and hemolymph were examined before and after tyramine addition followed by CYP2D6 inhibition by quinidine. Tyramine injection significantly increased ganglionic (4.98±0.27 μg/g to 9.17±1.21 μg/g wet weight; P<0.01) and hemolymph (10.13±1.24 μg/mL to 16.47±1.28 μg/mL, P<0.05) DA levels (FIGS. 19 and 20). The ganglionic and hemolymph DA level increases were blocked by quinidine exposure, demonstrating that the CYP2D6 enzyme was mediating this step. Ganglia were also exposed to THP, reticuline, DA, or codeine. Each resulted in significantly enhanced morphine levels, a phenomenon that was also significantly blocked by quinidine exposure, again demonstrating a role for CYP2D6 in the second part of the morphine biosynthetic pathway (FIGS. 15 and 20).

출처 및 근거

ORD 기록
ord-eae22b0c7c294073beeb048fda45eec6
출처 데이터셋
uspto-grants-2013_07
특허 번호
US08481559B2

연결된 노트

불러오는 중…